What We Do
Our innovative thinking and strategic advice helps clients in the payer, provider, digital health, and life sciences sectors realize their most ambitious organizational and operational visions by bridging the gap between their business today and their vision for the future.
At Oliver Wyman, we are focused on creating positive change in healthcare, but we know we can’t do it all ourselves. Together, with today's leading healthcare experts and innovators, we’ve built a community to share and shape ideas that will transform healthcare. We work to ensure industry transformation through generating meaningful client impact, delivering strategic insights, and creating a healthcare system that meets the needs of communities and companies.
On November 1, 2021, the Huron life sciences strategy consulting team joined Oliver Wyman, allowing us to bring our relentless pursuit of a better way to pharmaceutical, biotechnology, and medical device companies. Our new colleagues bring the expertise needed to help life sciences companies tackle their most pressing strategic questions, including increasingly complex commercialization and access-related issues.
What We Think

Designing A Healthcare System For The Next Decade
Reimagining how healthcare is delivered, paid for, and consumed
Read More
Healthcare in changing climate: Investing in resiliant solutions
Nearly half of the negative health consequences of global warming can be abated with targeted investment in vaccines, treatments and technology
Read MoreSteps To Improve Provider Performance In Medicare Advantage
Health systems don’t have to flee Medicare Advantage
Read MoreTake The Fork In The Road: AI Choices For Healthcare Leaders
Healthcare organizations face some heady decisions as they map out their generative artificial intelligence plan
Read More
Navigating M&A Opportunities Under The Trump Administration
Shifting regulatory and market dynamics will impact healthcare in 2025
Read More
Building A Value-Based Care Portfolio In Specialty Care
To get a hold of soaring costs, insurers have an opportunity to be more proactive and creative about partnering with specialists on value-based arrangements
Read More
Understanding The Risks And Rewards Of Care At Home
Care at Home is becoming a viable alternative for low-cost, high-quality care
Read More
Cyber Risk Due Diligence — A Game Changer For Healthcare M&A
A cyberattack can amount to a billion-dollar issue. As consolidation continues, leaders must make cybersecurity an integral part of strategy and due diligence
Read MoreSolutions

There is immense pressure across the entire healthcare landscape to provide higher quality care, improve the patient experience, lower costs, and reduce clinician burnout. Our Affordability and Quality Impact practice has deep expertise across lines of business to help organizations identify cost drivers, find efficiencies, improve quality of care, and more.
Who We Are
-
Deirdre Baggot Partner and Private Capital Leader
-
Andreas Eggert Partner and Europe Health and Life Sciences Leader
-
Martin Graf Partner and Government Services Leader
-
Minoo Javanmardian Partner and Provider Transformation Leader
-
Adeel Kheiri Partner
-
Ben Paik Partner and Americas Life Sciences Leader
-
Shivani Shah Executive Director and Health Innovation Center Leader
-
Sumit Sharma Partner and Head of Health and Life Sciences, IMEA
-
Chris Bernene Partner